Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
1158 RESULTS FOUND
Clinical Evaluation Comments on Three IMDRF Documents
June 5, 2019 |
Comments on National Coverage Analysis (NCA) for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer
May 28, 2019 | Letter
AdvaMed Accel University Technology transfer Best Practices Guide – Executive Summary
May 10, 2019 |
New York Times redline May 4, 2019
May 9, 2019 |
May 8, 2019 AdvaMed Letter Refining Value-Based Safe Harbor Proposals
May 8, 2019 | Letter
May 8, 2019 Letter to HHS re: AKS Safe Harbors for Value-Based Arrangements
May 8, 2019 | Letter
May 8, 2019 AdvaMed Letter Refining Value-Based Safe Harbor Proposals
May 8, 2019 |
Successful Industry-Academia Partnership Case Studies
May 7, 2019 |
Request for Comments on Modernizing FDA’s 510(k) Program
May 2, 2019 | Letter
Hydrochloric Acid Production Residual Risk and Technology Review
April 30, 2019 | Letter
Proposed National Coverage Determination for Transcatheter Aortic Valve Replacement
April 25, 2019 | Letter
AdvaMed Guiding Principles for Direct to Consumer (DTC) Device Advertising
April 23, 2019 | FAQs
Guiding Principles for Direct to Consumer Device Advertising
April 23, 2019 | White Paper
GMTA Market Access Subcommittee
April 18, 2019 |
GMTA General Assembly
April 18, 2019 |
Comments on Opioid Alternative Devices
April 11, 2019 | Letter
Device Tax Campaign Graphic
April 9, 2019 |
Comments on Ratesetting for New Diagnostic Tests Under PAMA 216
March 29, 2019 | Letter
AdvaMed 2019-2021 Committee and Board Chairs
March 26, 2019 |
Medical Device Tax: Claims vs. Facts
March 12, 2019 | Fact Sheet
Re: Docket No. FDA-2013-D-1445; Draft Guidance for Industry and FDA Staff on Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use
February 28, 2019 |
Re: Docket No. FDA-2013-D-1446; Draft Guidance for Industry and FDA Staff on SelfMonitoring Blood Glucose Test Systems for Over-the-Counter Use
February 28, 2019 |
Re: Docket No. FDA-2017-D-5570; Draft Guidance on Select Updates for Recommendations for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices
February 27, 2019 |
Re: Docket No. FDA-2017-D-5625; Draft Guidance on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies
February 27, 2019 |
Docket No. FDA-2018-N-3741: Request for Comments on Medical Device Servicing and Remanufacturing Activities; Public Workshop Docket No. FDA-2018-N-3741-0001: White Paper: Evaluating Whether Activities are Servicing or Remanufacturing
February 26, 2019 |

Pages